THE SKINCARE EDITIONClearer information. More informed choices.Independent by design
PeptiveloBETA
PEPTIVELO / THE SKINCARE EDITION

COSRX 6 Peptide Mini vs The Ordinary Copper Peptides

A comparison of selected label facts, with different sizes and disclosure limits. No clinical winner is established.

Editorial draft · Scientific review pending Updated 2026-10-20
Two formulas. A closer look at what matters. Change products
THE SHORT VERSION

What matters in 30 seconds.

The key findings, without the chemistry lesson.

01

What is documented?

This COSRX record is the 50 mL mini; The Ordinary record is 30 mL. Their selected peptide names and disclosures differ.[1][2]

Manufacturer labels

See ingredient differences
02

What does it mean for your purchase?

COSRX has no verified price in this record, so a fair unit-cost comparison remains unavailable. Do not substitute a 150 mL offer.[1][2]

Recorded prices · not a performance ranking

Understand the price
03

What has not been demonstrated?

This label comparison does not establish which finished serum works better or is safer. Individual tolerance and additional benefit cannot be predicted from the selected names.

Editorial interpretation of label information

Check the evidence

Before you choose: label facts do not establish which finished formula is safer or more effective. If you have a confirmed ingredient allergy, check the full label before buying.

Understand the evidence
SIDE BY SIDE

Ingredients, price and the gaps.

Compare selected label facts. Tap an ingredient to understand its name.

All recorded details · No product rankings

Compare recorded facts side by side. Missing information is not a negative rating.

Peptide serum label comparison: COSRX and The Ordinary
Compare the detailsTwo products.
The same questions.
Product basics
Presentation50 mL30 mL
FormatFirst-step cosmetic serumWater-based serum
How the brand says to use itThe manufacturer describes use after cleansing, as a first step. Follow current package directions.Manufacturer directions, not a personalized routine.Directions not recorded. Read the manufacturer's current instructions.Manufacturer directions, not a personalized routine.
Price & value
Recorded pricePrice not verifiedNo verified price for this size.$32.00 USDPrice recorded Excludes tax and shipping.
Price per mLPrice not verifiedRequires a verified price for this size.$1.07 / mL
What it contains and what it means
Peptides, explained

Peptides are small chains of the building blocks used in proteins. Their names identify ingredients, not quality scores. Open an explanation to learn what each one means.

Selected peptide names from the official mini label, not the full INCI list. Check your package for changes.Selected label ingredients, not the complete INCI list. See the manufacturer for the full formula.
How much of each ingredient?

A formula is the whole mix. A blend percentage does not tell us the amount of every ingredient.

Six describes the named peptide blend, not a percentage or an efficacy score.Manufacturer disclosure; not independently measured.Individual amounts not verifiedThe product name states 1% copper peptides. Amounts of the other selected peptides are not recorded.Manufacturer disclosure; not independently measured.Individual amounts not verified
Sources & limits
What we still cannot knowNot established
  • Verified price for this size
  • Complete ingredient list in this catalog
  • Independent comparative effectiveness
Not established
  • Complete ingredient list in this catalog
  • Independent comparative effectiveness
Label sourceCOSRX manufacturer label Label checked Label checked; not a clinical review.The Ordinary manufacturer label Label checked Label checked; not a clinical review.

Prices are dated USD observations. Ingredient selections are incomplete; matching names do not establish equivalent formulas or results.

What do the label differences mean?Exact names, disclosures and cost limits

Different presentations

Match the exact size before comparing an offer. This COSRX record is the 50 mL mini.[1][2]

Different disclosures

The Ordinary names 1% copper peptides. COSRX’s six-peptide name counts components; it is not a comparable concentration.[1][2]

Documented differences

The recorded COSRX mini is 50 mL; The Ordinary record is 30 mL. Both selected lists include Copper Tripeptide-1 and Acetyl Hexapeptide-8.[1][2]

Use this comparison for your decision

Confirm the bottle

Use the exact mini presentation when reviewing this pair.[1]

Read the full label

Selected lists omit non-peptide ingredients; they are not full-formula equivalence checks.[1][2]

LABEL FACTS AND THEIR LIMITS

What the sources tell us.

What do the source labels mean?

Human studies describe what happened in their participants and tested preparation. Laboratory studies examine a model, not clinical results in shoppers. Case reports describe individual events, not how often they occur.

Safety assessments review specified uses and concentrations. Manufacturer labels identify recorded product facts. Neither is a guarantee of results or individual tolerance. Source type is not a quality score.

What the labels document

Source type: Manufacturer label

This COSRX record is the 50 mL mini; The Ordinary record is 30 mL. Their selected peptide names and disclosures differ.[1][2]

Read the evidence and what it means

Source type: Manufacturer label

The recorded COSRX mini is 50 mL; The Ordinary record is 30 mL. Both selected lists include Copper Tripeptide-1 and Acetyl Hexapeptide-8.[1][2]

Amounts: disclosure is not measurement

Source type: Manufacturer label

Headline disclosures do not give verified individual amounts for every selected peptide.[1][2]

Read the evidence and what it means

Source type: Manufacturer label

COSRX: Six describes the named peptide blend, not a percentage or an efficacy score.[1]

Source type: Manufacturer label

The Ordinary: The product name states 1% copper peptides. Amounts of the other selected peptides are not recorded.[2]

What these sources cannot establish

Source type: Human ingredient study · Safety assessment

Recorded labels do not establish a clinical winner or years of safety for these complete formulas.[3][4]

Read the evidence and what it means

Source type: Human ingredient study · Safety assessment

The Argireline trial concerns a preparation, not either retail product in this pair. CIR addresses specified cosmetic safety uses, not a comparative benefit trial.[3][4]

Different study preparation. Not a test of either compared serum.

Editorial interpretation

This is a comparison of selected label information, not a complete clinical efficacy or safety review. Missing product-level evidence here is not evidence that either product is harmful or ineffective.

Cost and the exact presentation

Editorial interpretation

COSRX has no verified price in this record, so a fair unit-cost comparison remains unavailable. Do not substitute a 150 mL offer.

Read the evidence and what it means

Editorial interpretation

Selected names, no verified COSRX availability or comparable cost, and no finished-product head-to-head clinical evaluation. Scientific review pending.

What is recorded on the labels?

Source type: Manufacturer label

The paired manufacturer sources document the recorded product names and selected ingredients. These lists are incomplete, formulas may change, and manufacturer information is not independent clinical corroboration.[1][2]

Manufacturer links establish ingredient presence only. Scientific references support the research statements above. Formulas can change; check your purchased packaging.

A LITTLE MORE CLARITY

Questions about these products

Do shared names mean equal results?

No. Ingredient research and label overlap do not establish equal performance of finished formulas.[3][4]

Is there a fair cost comparison?

Not yet. No COSRX price is published here because the availability information requires clarification.[1]

Check the original sources

Research and safety assessments are separate from manufacturer labels.

How this comparison was preparedScope, review status and limitations

What we cannot tell from the label

Selected names, no verified COSRX availability or comparable cost, and no finished-product head-to-head clinical evaluation. Scientific review pending.

Read our methodology
CHECK THE CURRENT OFFER

Where to buy

Check the exact size, current price and shipping at the manufacturer.

COSRXThe 6 Peptide Skin Booster Serum Mini50 mL · Price not verified
View The 6 Peptide Skin Booster Serum Mini · 50 mL at COSRX Select the 50 mL option on the retailer’s page. Confirm the current price before checkout.
The OrdinaryMulti-Peptide + Copper Peptides 1% Serum30 mL · $32.00 USD · Recorded 2026-10-18
View Multi-Peptide + Copper Peptides 1% Serum · 30 mL at The Ordinary Select the 30 mL option on the retailer’s page. Confirm the current price before checkout.

No affiliate partnerships are active. Manufacturer links are ordinary links; we do not earn commissions from them. Recorded prices exclude tax and shipping and may have changed.

References

  1. Manufacturer labelCOSRX The 6 Peptide Skin Booster Serum Mini (50 mL): official label

    COSRX · Reference checked

    Evidence and limitations for reference 1
    What this supports here
    Exact mini label, selected names and presentation.
    What it cannot establish
    Commercial source; not a clinical trial. Page says unavailable while public feed marks the variant available, so price and availability are not published. Review widgets include unrelated sunscreen text and were not used.
    Commercial context and disclosures
    Published by the product seller.
    What we inspected
    Public source text inspected; underlying clinical dossiers not independently reanalysed.
  2. Manufacturer labelMulti-Peptide + Copper Peptides US product label

    The Ordinary · Reference checked

    Evidence and limitations for reference 2
    What this supports here
    Supports the selected peptide names, product name and 30 mL presentation.
    What it cannot establish
    Manufacturer claims and label checks do not establish clinical superiority over NIOD. Price observation dates are separate from this reference check.
    Commercial context and disclosures
    NIOD and The Ordinary are both DECIEM brands; these are commercial sources, not independent corroboration.
    What we inspected
    Public US product page
  3. Human ingredient study

    Wang Y, Wang M, Xiao S, Pan P, Li P, Huo J. 2013. American Journal of Clinical Dermatology, 14(2), 147–153.

    The Anti-Wrinkle Efficacy of Argireline, a Synthetic Hexapeptide, in Chinese Subjects: A Randomized, Placebo-Controlled Study

    DOI: 10.1007/s40257-013-0009-9

    American Journal of Clinical Dermatology / PubMed · Reference checked

    Evidence and limitations for reference 3
    What was studied
    Randomized, placebo-controlled; 60 Chinese participants, 3:1 allocation, four weeks.
    What was reported
    The abstract reports improved eye-area wrinkle measures with Argireline relative to placebo.
    What this supports here
    An example of ingredient research with a defined population and duration, rather than a test of either compared copper serum.
    What it cannot establish
    Four weeks in one population. Neither CAIS3 nor The Ordinary’s copper serum is the tested product identified in the abstract. No product winner or long-term safety conclusion follows.
    Commercial context and disclosures
    The publisher reports no funding and no declared conflicts. These are author declarations, not an independent audit.
    What we inspected
    Publisher abstract and acknowledgments inspected; full methods behind subscription were not reviewed.
    Publication status check
    No correction or retraction notice was seen on the inspected publisher page. This is not a comprehensive integrity clearance.
  4. Expert safety assessment

    Johnson W Jr, Bergfeld WF, Belsito DV, et al. 2018. International Journal of Toxicology.

    Safety Assessment of Tripeptide-1, Hexapeptide-12, Their Metal Salts and Fatty Acyl Derivatives, and Palmitoyl Tetrapeptide-7 as Used in Cosmetics

    DOI: 10.1177/1091581818807863

    Cosmetic Ingredient Review / International Journal of Toxicology · Reference checked

    Evidence and limitations for reference 4
    What was studied
    Expert assessment of specified cosmetic peptide ingredients; underlying final report released June 30, 2014.
    What was reported
    The panel’s favorable conclusion is conditional on the reviewed uses, concentrations and peptide identities.
    What this supports here
    Provides a scoped safe-use conclusion for specified peptide identities, practices and concentrations.
    What it cannot establish
    Does not test these finished products or establish their safety over years. NIOD’s exact label name is not silently equated with a different name in the report.
    Commercial context and disclosures
    CIR is funded by the Personal Care Products Council and describes its panel/review process as independent. Industry-submitted data are included; this is not a government approval.
    Source organization and funding context
    What we inspected
    2018 publisher full-text abstract, ingredient scope and introduction revisited; prior 2014 final-report discussion check retained. Not an independent toxicology reanalysis.